These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 39266515)

  • 1. Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion.
    Yoshida S; Yoshida T; Inukai K; Kato K; Yura Y; Hattori T; Enomoto A; Ohashi K; Okumura T; Ouchi N; Kawase H; Wettschureck N; Offermanns S; Murohara T; Takefuji M
    Nat Commun; 2024 Sep; 15(1):7638. PubMed ID: 39266515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
    Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
    Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Kinase N Promotes Stress-Induced Cardiac Dysfunction Through Phosphorylation of Myocardin-Related Transcription Factor A and Disruption of Its Interaction With Actin.
    Sakaguchi T; Takefuji M; Wettschureck N; Hamaguchi T; Amano M; Kato K; Tsuda T; Eguchi S; Ishihama S; Mori Y; Yura Y; Yoshida T; Unno K; Okumura T; Ishii H; Shimizu Y; Bando YK; Ohashi K; Ouchi N; Enomoto A; Offermanns S; Kaibuchi K; Murohara T
    Circulation; 2019 Nov; 140(21):1737-1752. PubMed ID: 31564129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
    J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
    Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
    Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.
    Shih YC; Chen CL; Zhang Y; Mellor RL; Kanter EM; Fang Y; Wang HC; Hung CT; Nong JY; Chen HJ; Lee TH; Tseng YS; Chen CN; Wu CC; Lin SL; Yamada KA; Nerbonne JM; Yang KC
    Circ Res; 2018 Apr; 122(8):1052-1068. PubMed ID: 29535165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
    Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
    Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
    Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
    Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts.
    Gupta SS; Zeglinski MR; Rattan SG; Landry NM; Ghavami S; Wigle JT; Klonisch T; Halayko AJ; Dixon IM
    Oncotarget; 2016 Nov; 7(48):78516-78531. PubMed ID: 27705938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
    Morine KJ; Qiao X; York S; Natov PS; Paruchuri V; Zhang Y; Aronovitz MJ; Karas RH; Kapur NK
    Circulation; 2018 Jul; 138(5):513-526. PubMed ID: 29487140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.
    Umbarkar P; Tousif S; Singh AP; Anderson JC; Zhang Q; Tallquist MD; Woodgett J; Lal H
    Circ Res; 2022 Sep; 131(7):620-636. PubMed ID: 36052698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-Abl-RACK1-FAK signaling axis promotes renal fibrosis in mice through regulating fibroblast-myofibroblast transition.
    Bao Q; Wang A; Hong W; Wang Y; Li B; He L; Yuan X; Ma G
    Cell Commun Signal; 2024 Apr; 22(1):247. PubMed ID: 38689280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Smad7 Induction Protects the Remodeling Pressure-Overloaded Heart.
    Humeres C; Shinde AV; Tuleta I; Hernandez SC; Hanna A; Huang S; Venugopal H; Aguilan JT; Conway SJ; Sidoli S; Frangogiannis NG
    Circ Res; 2024 Jul; 135(3):453-469. PubMed ID: 38899461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.
    Bagchi RA; Roche P; Aroutiounova N; Espira L; Abrenica B; Schweitzer R; Czubryt MP
    BMC Biol; 2016 Mar; 14():21. PubMed ID: 26988708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation.
    Chavkin NW; Sano S; Wang Y; Oshima K; Ogawa H; Horitani K; Sano M; MacLauchlan S; Nelson A; Setia K; Vippa T; Watanabe Y; Saucerman JJ; Hirschi KK; Gokce N; Walsh K
    J Am Heart Assoc; 2021 Jul; 10(13):e019904. PubMed ID: 34155901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis.
    Wu J; Subbaiah KCV; Xie LH; Jiang F; Khor ES; Mickelsen D; Myers JR; Tang WHW; Yao P
    Circ Res; 2020 Aug; 127(6):827-846. PubMed ID: 32611237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulators of cardiac fibroblast cell state.
    Bretherton R; Bugg D; Olszewski E; Davis J
    Matrix Biol; 2020 Sep; 91-92():117-135. PubMed ID: 32416242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.